{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:09:54Z","timestamp":1783008594786,"version":"3.54.5"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,31]]},"DOI":"10.7759\/cureus.36955","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T13:05:19Z","timestamp":1680267919000},"source":"Crossref","is-referenced-by-count":27,"title":["COVID-19 Induced Postural Orthostatic Tachycardia Syndrome (POTS): A Review"],"prefix":"10.7759","author":[{"given":"Deobrat","family":"Mallick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lokesh","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabal","family":"Chourasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miana R","family":"Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanica","family":"Yashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Surani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"World Health Organization. WHO coronavirus (COVID-19) dashboard. (2019). Accessed: March 31, 2023: https:\/\/covid19.who.int\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1098","article-title":"Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study","volume":"373","author":"Daugherty SE","year":"2021","unstructured":"Daugherty SE, Guo Y, Heath K, et al.. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2021, 373:n1098. 10.1136\/bmj.n1098","journal-title":"BMJ"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10132945","article-title":"Long-term outcomes of patients with coronavirus disease 2019 at one year after hospital discharge","volume":"10","author":"Maestre-Mu\u00f1iz MM","year":"2021","unstructured":"Maestre-Mu\u00f1iz MM, Arias \u00c1, Mata-V\u00e1zquez E, et al.. Long-term outcomes of patients with coronavirus disease 2019 at one year after hospital discharge. J Clin Med. 2021, 10:10.3390\/jcm10132945","journal-title":"J Clin Med"},{"key":"ref4","unstructured":"National Library of Medicine. COVID-19 rapid guideline: managing the long-term effects of COVID-19. (2020). Accessed: March 31, 2023: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK567261\/."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01433-3","article-title":"Long COVID in a prospective cohort of home-isolated patients","volume":"27","author":"Blomberg B","year":"2021","unstructured":"Blomberg B, Mohn KG, Brokstad KA, et al.. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021, 27:1607-13. 10.1038\/s41591-021-01433-3","journal-title":"Nat Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-021-01666-x","article-title":"Long COVID, a comprehensive systematic scoping review","volume":"49","author":"Akbarialiabad H","year":"2021","unstructured":"Akbarialiabad H, Taghrir MH, Abdollahi A, et al.. Long COVID, a comprehensive systematic scoping review. Infection. 2021, 49:1163-86. 10.1007\/s15010-021-01666-x","journal-title":"Infection"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2021.102841","article-title":"Preparing for the long-haul: Autonomic complications of COVID-19","volume":"235","author":"Larsen NW","year":"2021","unstructured":"Larsen NW, Stiles LE, Miglis MG. Preparing for the long-haul: Autonomic complications of COVID-19. Auton Neurosci. 2021, 235:102841. 10.1016\/j.autneu.2021.102841","journal-title":"Auton Neurosci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2020-0896","article-title":"Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies","volume":"21","author":"Dani M","year":"2021","unstructured":"Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, Lim PB. Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. Clin Med (Lond). 2021, 21:e63-7. 10.7861\/clinmed.2020-0896","journal-title":"Clin Med (Lond)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.624968","article-title":"COVID-19 dysautonomia","volume":"12","author":"Goodman BP","year":"2021","unstructured":"Goodman BP, Khoury JA, Blair JE, Grill MF. COVID-19 dysautonomia. Front Neurol. 2021, 12:624968. 10.3389\/fneur.2021.624968","journal-title":"Front Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-020-00727-9","article-title":"A case report of postural tachycardia syndrome after COVID-19","volume":"30","author":"Miglis MG","year":"2020","unstructured":"Miglis MG, Prieto T, Shaik R, Muppidi S, Sinn DI, Jaradeh S. A case report of postural tachycardia syndrome after COVID-19. Clin Auton Res. 2020, 30:449-51. 10.1007\/s10286-020-00727-9","journal-title":"Clin Auton Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.19102\/icrm.2020.111102","article-title":"New-onset postural orthostatic tachycardia syndrome following coronavirus disease 2019 infection","volume":"11","author":"Kanjwal K","year":"2020","unstructured":"Kanjwal K, Jamal S, Kichloo A, Grubb BP. New-onset postural orthostatic tachycardia syndrome following coronavirus disease 2019 infection. J Innov Card Rhythm Manag. 2020, 11:4302-4. 10.19102\/icrm.2020.111102","journal-title":"J Innov Card Rhythm Manag"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2008.01407.x","article-title":"Postural tachycardia syndrome (POTS)","volume":"20","author":"Low PA","year":"2009","unstructured":"Low PA, Sandroni P, Joyner M, Shen WK. Postural tachycardia syndrome (POTS). J Cardiovasc Electrophysiol. 2009, 20:352-8. 10.1111\/j.1540-8167.2008.01407.x","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.43.1_part_1.132","article-title":"Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia?","volume":"43","author":"Schondorf R","year":"1993","unstructured":"Schondorf R, Low PA. Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia?. Neurology. 1993, 43:132-7. 10.1212\/wnl.43.1_part_1.132","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00220","article-title":"Neuronal and hormonal perturbations in postural tachycardia syndrome","volume":"5","author":"Mar PL","year":"2014","unstructured":"Mar PL, Raj SR. Neuronal and hormonal perturbations in postural tachycardia syndrome. Front Physiol. 2014, 5:220. 10.3389\/fphys.2014.00220","journal-title":"Front Physiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/14017431.2017.1355068","article-title":"The role of autoantibodies in the syndromes of orthostatic intolerance: a systematic review","volume":"51","author":"Ruzieh M","year":"2017","unstructured":"Ruzieh M, Batizy L, Dasa O, Oostra C, Grubb B. The role of autoantibodies in the syndromes of orthostatic intolerance: a systematic review. Scand Cardiovasc J. 2017, 51:243-7. 10.1080\/14017431.2017.1355068","journal-title":"Scand Cardiovasc J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-199802000-00005","article-title":"Relation of blood volume and blood pressure in orthostatic intolerance","volume":"315","author":"Jacob G; Biaggioni I; Mosqueda-Garcia R","year":"1998","unstructured":"Jacob G; Biaggioni I; Mosqueda-Garcia R. Relation of blood volume and blood pressure in orthostatic intolerance. Am. J. Med. Sci. 1998, 315:95-100. 10.1097\/00000441-199802000-00005","journal-title":"Am. J. Med. Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000160356.97313.5D","article-title":"Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome","volume":"111","author":"Raj SR","year":"2005","unstructured":"Raj SR, Biaggioni I, Yamhure PC, Black BK, Paranjape SY, Byrne DW, Robertson D. Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome. Circulation. 2005, 111:1574-82. 10.1161\/01.CIR.0000160356.97313.5D","journal-title":"Circulation"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2021.07.004","article-title":"Post-COVID-19 tachycardia syndrome: A distinct phenotype of post-acute COVID-19 syndrome","volume":"134","author":"St\u00e5hlberg M","year":"2021","unstructured":"St\u00e5hlberg M, Reistam U, Fedorowski A, et al.. Post-COVID-19 tachycardia syndrome: A distinct phenotype of post-acute COVID-19 syndrome. Am J Med. 2021, 134:1451-6. 10.1016\/j.amjmed.2021.07.004","journal-title":"Am J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.1012668","article-title":"Characterization of autonomic symptom burden in long COVID: A global survey of 2,314 adults","volume":"13","author":"Larsen NW","year":"2022","unstructured":"Larsen NW, Stiles LE, Shaik R, et al.. Characterization of autonomic symptom burden in long COVID: A global survey of 2,314 adults. Front Neurol. 2022, 13:1012668. 10.3389\/fneur.2022.1012668","journal-title":"Front Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000444","article-title":"Syncope","volume":"23","author":"Cheshire WP Jr","year":"2017","unstructured":"Cheshire WP Jr. Syncope. Continuum (Minneap Minn). 2017, 23:335-58. 10.1212\/CON.0000000000000444","journal-title":"Continuum (Minneap Minn)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1991.70.2.523","article-title":"Initial blood pressure fall on stand up and exercise explained by changes in total peripheral resistance","volume":"70","author":"Sprangers RL","year":"1991","unstructured":"Sprangers RL, Wesseling KH, Imholz AL, Imholz BP, Wieling W. Initial blood pressure fall on stand up and exercise explained by changes in total peripheral resistance. J Appl Physiol (1985). 1991, 70:523-30. 10.1152\/jappl.1991.70.2.523","journal-title":"J Appl Physiol (1985)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-021-00803-8","article-title":"Autonomic dysfunction following COVID-19 infection: an early experience","volume":"31","author":"Shouman K","year":"2021","unstructured":"Shouman K, Vanichkachorn G, Cheshire WP, et al.. Autonomic dysfunction following COVID-19 infection: an early experience. Clin Auton Res. 2021, 31:385-94. 10.1007\/s10286-021-00803-8","journal-title":"Clin Auton Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4065\/82.3.308","article-title":"Postural orthostatic tachycardia syndrome: the Mayo clinic experience","volume":"82","author":"Thieben MJ; Sandroni P; Sletten DM","year":"2007","unstructured":"Thieben MJ; Sandroni P; Sletten DM. Postural orthostatic tachycardia syndrome: the Mayo clinic experience. Mayo Clin. Proc. 2007, 82:308-313. 10.4065\/82.3.308","journal-title":"Mayo Clin. Proc"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-009-0045-y","article-title":"Distal sudomotor findings in postural tachycardia syndrome","volume":"20","author":"Peltier AC","year":"2010","unstructured":"Peltier AC, Garland E, Raj SR, et al.. Distal sudomotor findings in postural tachycardia syndrome. Clin Auton Res. 2010, 20:93-9. 10.1007\/s10286-009-0045-y","journal-title":"Clin Auton Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-005-0282-7","article-title":"The value of autonomic testing in postural tachycardia syndrome","volume":"15","author":"Al-Shekhlee A","year":"2005","unstructured":"Al-Shekhlee A, Lindenberg JR, Hachwi RN, Chelimsky TC. The value of autonomic testing in postural tachycardia syndrome. Clin Auton Res. 2005, 15:219-22. 10.1007\/s10286-005-0282-7","journal-title":"Clin Auton Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084716","article-title":"Structural and functional small fiber abnormalities in the neuropathic postural tachycardia syndrome","volume":"8","author":"Gibbons CH","year":"2013","unstructured":"Gibbons CH, Bonyhay I, Benson A, Wang N, Freeman R. Structural and functional small fiber abnormalities in the neuropathic postural tachycardia syndrome. PLoS One. 2013, 8:e84716. 10.1371\/journal.pone.0084716","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.11803","article-title":"Vagal and sympathetic function in neuropathic postural tachycardia syndrome","volume":"73","author":"Jacob G","year":"2019","unstructured":"Jacob G, Diedrich L, Sato K, et al.. Vagal and sympathetic function in neuropathic postural tachycardia syndrome. Hypertension. 2019, 73:1087-96. 10.1161\/HYPERTENSIONAHA.118.11803","journal-title":"Hypertension"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000267663.05398.40","article-title":"The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome","volume":"69","author":"Garland EM","year":"2007","unstructured":"Garland EM, Raj SR, Black BK, Harris PA, Robertson D. The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome. Neurology. 2007, 69:790-8. 10.1212\/01.wnl.0000267663.05398.40","journal-title":"Neurology"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1042\/CS20050254","article-title":"Increased plasma angiotensin II in postural tachycardia syndrome (POTS) is related to reduced blood flow and blood volume","volume":"110","author":"Stewart JM","year":"2006","unstructured":"Stewart JM, Glover JL, Medow MS. Increased plasma angiotensin II in postural tachycardia syndrome (POTS) is related to reduced blood flow and blood volume. Clin Sci (Lond). 2006, 110:255-63. 10.1042\/CS20050254","journal-title":"Clin Sci (Lond)"},{"key":"ref30","unstructured":"Centers for Disease Control and Prevention. Post-COVID conditions: information for healthcare providers. (2022). Accessed: March 31, 2023: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/clinical-care\/post-covid-conditions.html."},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2021.100100","article-title":"Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms","volume":"4","author":"Wallukat G","year":"2021","unstructured":"Wallukat G, Hohberger B, Wenzel K, et al.. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun. 2021, 4:100100. 10.1016\/j.jtauto.2021.100100","journal-title":"J Transl Autoimmun"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10108-x","article-title":"Immune-mediated neurological syndromes in SARS-CoV-2-infected patients","volume":"268","author":"Guilmot A","year":"2021","unstructured":"Guilmot A, Maldonado Slootjes S, Sellimi A, et al.. Immune-mediated neurological syndromes in SARS-CoV-2-infected patients. J Neurol. 2021, 268:751-7. 10.1007\/s00415-020-10108-x","journal-title":"J Neurol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.147610","article-title":"Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury","volume":"6","author":"Andargie TE","year":"2021","unstructured":"Andargie TE, Tsuji N, Seifuddin F, et al.. Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury. JCI Insight. 2021, 6:10.1172\/jci.insight.147610","journal-title":"JCI Insight"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-021-02696-0","article-title":"Could SARS-CoV-2 spike protein be responsible for long-COVID syndrome?","volume":"59","author":"Theoharides TC","year":"2022","unstructured":"Theoharides TC. Could SARS-CoV-2 spike protein be responsible for long-COVID syndrome?. Mol Neurobiol. 2022, 59:1850-61. 10.1007\/s12035-021-02696-0","journal-title":"Mol Neurobiol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10655-x","article-title":"Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex","volume":"269","author":"Hugon J","year":"2022","unstructured":"Hugon J, Msika EF, Queneau M, Farid K, Paquet C. Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex. J Neurol. 2022, 269:44-6. 10.1007\/s00415-021-10655-x","journal-title":"J Neurol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-020-00895-4","article-title":"Neurological manifestations of COVID-19: available evidences and a new paradigm","volume":"26","author":"Khatoon F","year":"2020","unstructured":"Khatoon F, Prasad K, Kumar V. Neurological manifestations of COVID-19: available evidences and a new paradigm. J Neurovirol. 2020, 26:619-30. 10.1007\/s13365-020-00895-4","journal-title":"J Neurovirol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04575-3","article-title":"Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients","volume":"41","author":"Yachou Y","year":"2020","unstructured":"Yachou Y, El Idrissi A, Belapasov V, Ait Benali S. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurol Sci. 2020, 41:2657-69. 10.1007\/s10072-020-04575-3","journal-title":"Neurol Sci"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25728","article-title":"The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients","volume":"92","author":"Li YC","year":"2020","unstructured":"Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020, 92:552-5. 10.1002\/jmv.25728","journal-title":"J Med Virol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.0c00122","article-title":"Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms","volume":"11","author":"Baig AM","year":"2020","unstructured":"Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020, 11:995-8. 10.1021\/acschemneuro.0c00122","journal-title":"ACS Chem Neurosci"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1177\/17590914211057635","article-title":"Covid-19-induced dysautonomia: a menace of sympathetic storm","volume":"13","author":"Al-Kuraishy HM","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Qusti S, Alshammari EM, Gyebi GA, Batiha GE. Covid-19-induced dysautonomia: a menace of sympathetic storm. ASN Neuro. 2021, 13:17590914211057635. 10.1177\/17590914211057635","journal-title":"ASN Neuro"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.0c00793","article-title":"Persistent brainstem dysfunction in long-COVID: a hypothesis","volume":"12","author":"Yong SJ","year":"2021","unstructured":"Yong SJ. Persistent brainstem dysfunction in long-COVID: a hypothesis. ACS Chem Neurosci. 2021, 12:573-80. 10.1021\/acschemneuro.0c00793","journal-title":"ACS Chem Neurosci"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2020.12.007","article-title":"The possible association between COVID-19 and postural tachycardia syndrome","volume":"18","author":"Goldstein DS","year":"2021","unstructured":"Goldstein DS. The possible association between COVID-19 and postural tachycardia syndrome. Heart Rhythm. 2021, 18:508-9. 10.1016\/j.hrthm.2020.12.007","journal-title":"Heart Rhythm"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.667036","article-title":"Selective vagus nerve stimulation as a therapeutic approach for the treatment of ARDS: a rationale for neuro-immunomodulation in COVID-19 disease","volume":"15","author":"Mastitskaya S","year":"2021","unstructured":"Mastitskaya S, Thompson N, Holder D. Selective vagus nerve stimulation as a therapeutic approach for the treatment of ARDS: a rationale for neuro-immunomodulation in COVID-19 disease. Front Neurosci. 2021, 15:667036. 10.3389\/fnins.2021.667036","journal-title":"Front Neurosci"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12895","article-title":"The face of postural tachycardia syndrome - insights from a large cross-sectional online community-based survey","volume":"286","author":"Shaw BH","year":"2019","unstructured":"Shaw BH, Stiles LE, Bourne K, et al.. The face of postural tachycardia syndrome - insights from a large cross-sectional online community-based survey. J Intern Med. 2019, 286:438-48. 10.1111\/joim.12895","journal-title":"J Intern Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.08.013","article-title":"Postural tachycardia syndrome: a heterogeneous and multifactorial disorder","volume":"87","author":"Benarroch EE","year":"2012","unstructured":"Benarroch EE. Postural tachycardia syndrome: a heterogeneous and multifactorial disorder. Mayo Clin Proc. 2012, 87:1214-25. 10.1016\/j.mayocp.2012.08.013","journal-title":"Mayo Clin Proc"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2016.10.004","article-title":"The genesis and presentation of anxiety in disorders of autonomic overexcitation","volume":"203","author":"Owens AP","year":"2017","unstructured":"Owens AP, Low DA, Iodice V, Critchley HD, Mathias CJ. The genesis and presentation of anxiety in disorders of autonomic overexcitation. Auton Neurosci. 2017, 203:81-7. 10.1016\/j.autneu.2016.10.004","journal-title":"Auton Neurosci"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac249","article-title":"Fear conditioning as a pathogenic mechanism in the postural tachycardia syndrome","volume":"145","author":"Norcliffe-Kaufmann L","year":"2022","unstructured":"Norcliffe-Kaufmann L, Palma JA, Martinez J, Camargo C, Kaufmann H. Fear conditioning as a pathogenic mechanism in the postural tachycardia syndrome. Brain. 2022, 145:3763-9. 10.1093\/brain\/awac249","journal-title":"Brain"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2015.10.052","article-title":"Gastrointestinal dysfunction in postural tachycardia syndrome","volume":"359","author":"Wang LB","year":"2015","unstructured":"Wang LB, Culbertson CJ, Deb A, Morgenshtern K, Huang H, Hohler AD. Gastrointestinal dysfunction in postural tachycardia syndrome. J Neurol Sci. 2015, 359:193-6. 10.1016\/j.jns.2015.10.052","journal-title":"J Neurol Sci"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2018.03.004","article-title":"Cognitive and psychological issues in postural tachycardia syndrome","volume":"215","author":"Raj V","year":"2018","unstructured":"Raj V, Opie M, Arnold AC. Cognitive and psychological issues in postural tachycardia syndrome. Auton Neurosci. 2018, 215:46-55. 10.1016\/j.autneu.2018.03.004","journal-title":"Auton Neurosci"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1002\/nau.22971","article-title":"Overactive bladder and autonomic dysfunction: Lower urinary tract symptoms in females with postural tachycardia syndrome","volume":"36","author":"Kaufman MR","year":"2017","unstructured":"Kaufman MR, Chang-Kit L, Raj SR, et al.. Overactive bladder and autonomic dysfunction: Lower urinary tract symptoms in females with postural tachycardia syndrome. Neurourol Urodyn. 2017, 36:610-3. 10.1002\/nau.22971","journal-title":"Neurourol Urodyn"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2016.12.1.75","article-title":"Dermatological manifestations of postural tachycardia syndrome are common and diverse","volume":"12","author":"Huang H","year":"2016","unstructured":"Huang H, Deb A, Culbertson C, Morgenshtern K, DePold Hohler A. Dermatological manifestations of postural tachycardia syndrome are common and diverse. J Clin Neurol. 2016, 12:75-8. 10.3988\/jcn.2016.12.1.75","journal-title":"J Clin Neurol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-011-0119-5","article-title":"Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome","volume":"21","author":"Freeman R","year":"2011","unstructured":"Freeman R, Wieling W, Axelrod FB, et al.. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011, 21:69-72. 10.1007\/s10286-011-0119-5","journal-title":"Clin Auton Res"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1007\/BF01845493","article-title":"Orthostatic intolerance and orthostatic tachycardia: a heterogeneous disorder","volume":"5","author":"Khurana RK","year":"1995","unstructured":"Khurana RK. Orthostatic intolerance and orthostatic tachycardia: a heterogeneous disorder. Clin Auton Res. 1995, 5:12-8. 10.1007\/BF01845493","journal-title":"Clin Auton Res"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1111\/jch.13521","article-title":"Orthostatic hypotension: From pathophysiology to clinical applications and therapeutic considerations","volume":"21","author":"Magkas N","year":"2019","unstructured":"Magkas N, Tsioufis C, Thomopoulos C, et al.. Orthostatic hypotension: From pathophysiology to clinical applications and therapeutic considerations. J Clin Hypertens (Greenwich). 2019, 21:546-54. 10.1111\/jch.13521","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-020-00796-5","article-title":"Drug-related orthostatic hypotension: Beyond anti-hypertensive medications","volume":"37","author":"Rivasi G","year":"2020","unstructured":"Rivasi G, Rafanelli M, Mossello E, Brignole M, Ungar A. Drug-related orthostatic hypotension: Beyond anti-hypertensive medications. Drugs Aging. 2020, 37:725-38. 10.1007\/s40266-020-00796-5","journal-title":"Drugs Aging"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000905","article-title":"Drug-induced arrhythmias: a scientific statement from the American Heart Association","volume":"142","author":"Tisdale JE","year":"2020","unstructured":"Tisdale JE, Chung MK, Campbell KB, Hammadah M, Joglar JA, Leclerc J, Rajagopalan B. Drug-induced arrhythmias: a scientific statement from the American Heart Association. Circulation. 2020, 142:e214-33. 10.1161\/CIR.0000000000000905","journal-title":"Circulation"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000310","article-title":"2015 ACC\/AHA\/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"133","author":"Page RL","year":"2016","unstructured":"Page RL, Joglar JA, Caldwell MA, et al.. 2015 ACC\/AHA\/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2016, 133:e471-505. 10.1161\/CIR.0000000000000310","journal-title":"Circulation"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy037","article-title":"2018 ESC Guidelines for the diagnosis and management of syncope","volume":"39","author":"Brignole M","year":"2018","unstructured":"Brignole M, Moya A, de Lange FJ, et al.. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018, 39:1883-948. 10.1093\/eurheartj\/ehy037","journal-title":"Eur Heart J"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.10.005","article-title":"Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review","volume":"28","author":"Fiolet T","year":"2022","unstructured":"Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infect. 2022, 28:202-21. 10.1016\/j.cmi.2021.10.005","journal-title":"Clin Microbiol Infect"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14837","article-title":"A case of postural orthostatic tachycardia syndrome secondary to the messenger RNA COVID-19 vaccine","volume":"13","author":"Reddy S","year":"2021","unstructured":"Reddy S, Reddy S, Arora M. A case of postural orthostatic tachycardia syndrome secondary to the messenger RNA COVID-19 vaccine. Cureus. 2021, 13:e14837. 10.7759\/cureus.14837","journal-title":"Cureus"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29837","article-title":"A Hitchhiker's Guide to worldwide COVID-19 vaccinations: a detailed review of monovalent and bivalent vaccine schedules, COVID-19 vaccine side effects, and effectiveness against omicron and delta variants","volume":"14","author":"Goyal L","year":"2022","unstructured":"Goyal L, Zapata M, Ajmera K, Chaurasia P, Pandit R, Pandit T. A Hitchhiker's Guide to worldwide COVID-19 vaccinations: a detailed review of monovalent and bivalent vaccine schedules, COVID-19 vaccine side effects, and effectiveness against omicron and delta variants. Cureus. 2022, 14:e29837. 10.7759\/cureus.29837","journal-title":"Cureus"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1038\/s44161-022-00177-8","article-title":"Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS-Cov-2 Infection","author":"Kwan AC; Ebinger JE; We J","year":"2022","unstructured":"Kwan AC; Ebinger JE; We J. Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS-Cov-2 Infection. Nat. Cardiovasc. Res. 2022, 10.1038\/s44161-022-00177-8","journal-title":"Nat. Cardiovasc. Res"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-010-0091-5","article-title":"Effects of exercise training on arterial-cardiac baroreflex function in POTS","volume":"21","author":"Galbreath MM","year":"2011","unstructured":"Galbreath MM, Shibata S, VanGundy TB, Okazaki K, Fu Q, Levine BD. Effects of exercise training on arterial-cardiac baroreflex function in POTS. Clin Auton Res. 2011, 21:73-80. 10.1007\/s10286-010-0091-5","journal-title":"Clin Auton Res"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-041818-011630","article-title":"Postural orthostatic tachycardia syndrome: mechanisms and new therapies","volume":"71","author":"Mar PL","year":"2020","unstructured":"Mar PL, Raj SR. Postural orthostatic tachycardia syndrome: mechanisms and new therapies. Annu Rev Med. 2020, 71:235-48. 10.1146\/annurev-med-041818-011630","journal-title":"Annu Rev Med"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2015.03.029","article-title":"2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope","volume":"12","author":"Sheldon RS","year":"2015","unstructured":"Sheldon RS, Grubb BP 2nd, Olshansky B, et al.. 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015, 12:e41-63. 10.1016\/j.hrthm.2015.03.029","journal-title":"Heart Rhythm"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00367.2014","article-title":"Acute volume loading and exercise capacity in postural tachycardia syndrome","volume":"117","author":"Figueroa RA","year":"2014","unstructured":"Figueroa RA, Arnold AC, Nwazue VC, et al.. Acute volume loading and exercise capacity in postural tachycardia syndrome. J Appl Physiol (1985). 2014, 117:663-8. 10.1152\/japplphysiol.00367.2014","journal-title":"J Appl Physiol (1985)"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1007\/BF02291387","article-title":"Hemodynamic and symptomatic effects of acute interventions on tilt in patients with postural tachycardia syndrome","volume":"10","author":"Gordon VM","year":"2000","unstructured":"Gordon VM, Opfer-Gehrking TL, Novak V, Low PA. Hemodynamic and symptomatic effects of acute interventions on tilt in patients with postural tachycardia syndrome. Clin Auton Res. 2000, 10:29-33. 10.1007\/BF02291387","journal-title":"Clin Auton Res"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.96.2.575","article-title":"Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia","volume":"96","author":"Jacob G","year":"1997","unstructured":"Jacob G, Shannon JR, Black B, Biaggioni I, Mosqueda-Garcia R, Robertson RM, Robertson D. Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia. Circulation. 1997, 96:575-80. 10.1161\/01.cir.96.2.575","journal-title":"Circulation"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-008-0487-7","article-title":"POTS versus deconditioning: the same or different?","volume":"18","author":"Joyner MJ","year":"2008","unstructured":"Joyner MJ, Masuki S. POTS versus deconditioning: the same or different?. Clin Auton Res. 2008, 18:300-7. 10.1007\/s10286-008-0487-7","journal-title":"Clin Auton Res"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000156540.25707.af","article-title":"Endurance exercise training in orthostatic intolerance: a randomized, controlled trial","volume":"45","author":"Winker R","year":"2005","unstructured":"Winker R, Barth A, Bidmon D, et al.. Endurance exercise training in orthostatic intolerance: a randomized, controlled trial. Hypertension. 2005, 45:391-8. 10.1161\/01.HYP.0000156540.25707.af","journal-title":"Hypertension"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2018.02.003","article-title":"Managing fatigue in postural tachycardia syndrome (PoTS): The Newcastle approach","volume":"215","author":"Strassheim V","year":"2018","unstructured":"Strassheim V, Welford J, Ballantine R, Newton JL. Managing fatigue in postural tachycardia syndrome (PoTS): The Newcastle approach. Auton Neurosci. 2018, 215:56-61. 10.1016\/j.autneu.2018.02.003","journal-title":"Auton Neurosci"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1007\/s10880-018-9558-7","article-title":"Youth with chronic pain and postural orthostatic tachycardia syndrome (POTS): Treatment mediators of improvement in functional disability","volume":"25","author":"Junghans-Rutelonis AN","year":"2018","unstructured":"Junghans-Rutelonis AN, Craner JR, Ale CM, Harbeck-Weber C, Fischer PR, Weiss KE. Youth with chronic pain and postural orthostatic tachycardia syndrome (POTS): Treatment mediators of improvement in functional disability. J Clin Psychol Med Settings. 2018, 25:471-84. 10.1007\/s10880-018-9558-7","journal-title":"J Clin Psychol Med Settings"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2014.10.012","article-title":"Effects of patient-controlled abdominal compression on standing systolic blood pressure in adults with orthostatic hypotension","volume":"96","author":"Figueroa JJ","year":"2015","unstructured":"Figueroa JJ, Singer W, Sandroni P, et al.. Effects of patient-controlled abdominal compression on standing systolic blood pressure in adults with orthostatic hypotension. Arch Phys Med Rehabil. 2015, 96:505-10. 10.1016\/j.apmr.2014.10.012","journal-title":"Arch Phys Med Rehabil"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.11.040","article-title":"Compression garment reduces orthostatic tachycardia and symptoms in patients with postural orthostatic tachycardia syndrome","volume":"77","author":"Bourne KM","year":"2021","unstructured":"Bourne KM, Sheldon RS, Hall J, et al.. Compression garment reduces orthostatic tachycardia and symptoms in patients with postural orthostatic tachycardia syndrome. J Am Coll Cardiol. 2021, 77:285-96. 10.1016\/j.jacc.2020.11.040","journal-title":"J Am Coll Cardiol"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1972.32.2.213","article-title":"Importance of the splanchnic vascular bed in human blood pressure regulation","volume":"32","author":"Rowell LB","year":"1972","unstructured":"Rowell LB, Detry JM, Blackmon JR, Wyss C. Importance of the splanchnic vascular bed in human blood pressure regulation. J Appl Physiol. 1972, 32:213-20. 10.1152\/jappl.1972.32.2.213","journal-title":"J Appl Physiol"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00460","article-title":"Efficacy of \u03b2-blockers on postural tachycardia syndrome in children and adolescents: a systematic review and meta-analysis","volume":"7","author":"Deng X","year":"2019","unstructured":"Deng X, Zhang Y, Liao Y, Du J. Efficacy of \u03b2-blockers on postural tachycardia syndrome in children and adolescents: a systematic review and meta-analysis. Front Pediatr. 2019, 7:460. 10.3389\/fped.2019.00460","journal-title":"Front Pediatr"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.846501","article-title":"Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more","volume":"120","author":"Raj SR","year":"2009","unstructured":"Raj SR, Black BK, Biaggioni I, Paranjape SY, Ramirez M, Dupont WD, Robertson D. Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more. Circulation. 2009, 120:725-34. 10.1161\/CIRCULATIONAHA.108.846501","journal-title":"Circulation"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-017-0252-1","article-title":"Ivabradine for the treatment of postural orthostatic tachycardia syndrome: A systematic review","volume":"18","author":"Gee ME","year":"2018","unstructured":"Gee ME, Watkins AK, Brown JN, Young EJ. Ivabradine for the treatment of postural orthostatic tachycardia syndrome: A systematic review. Am J Cardiovasc Drugs. 2018, 18:195-204. 10.1007\/s40256-017-0252-1","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-227789","article-title":"Is ivabradine a wonder drug for atypical POTS?","volume":"12","author":"Cheema MA","year":"2019","unstructured":"Cheema MA, Zain MA, Ullah W, Cheema K. Is ivabradine a wonder drug for atypical POTS?. BMJ Case Rep. 2019, 12:10.1136\/bcr-2018-227789","journal-title":"BMJ Case Rep"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euq390","article-title":"Single centre experience of ivabradine in postural orthostatic tachycardia syndrome","volume":"13","author":"McDonald C","year":"2011","unstructured":"McDonald C, Frith J, Newton JL. Single centre experience of ivabradine in postural orthostatic tachycardia syndrome. Europace. 2011, 13:427-30. 10.1093\/europace\/euq390","journal-title":"Europace"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eut226","article-title":"Ivabradine in treatment of sinus tachycardia mediated vasovagal syncope","volume":"16","author":"Sutton R","year":"2014","unstructured":"Sutton R, Salukhe TV, Franzen-McManus AC, Collins A, Lim PB, Francis DP. Ivabradine in treatment of sinus tachycardia mediated vasovagal syncope. Europace. 2014, 16:284-8. 10.1093\/europace\/eut226","journal-title":"Europace"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.12.029","article-title":"Randomized trial of ivabradine in patients with hyperadrenergic postural orthostatic tachycardia syndrome","volume":"77","author":"Taub PR","year":"2021","unstructured":"Taub PR, Zadourian A, Lo HC, Ormiston CK, Golshan S, Hsu JC. Randomized trial of ivabradine in patients with hyperadrenergic postural orthostatic tachycardia syndrome. J Am Coll Cardiol. 2021, 77:861-71. 10.1016\/j.jacc.2020.12.029","journal-title":"J Am Coll Cardiol"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197907123010202","article-title":"Mineralocorticoid-induced hypertension in patients with orthostatic hypotension","volume":"301","author":"Chobanian AV","year":"1979","unstructured":"Chobanian AV, Volicer L, Tifft CP, Gavras H, Liang CS, Faxon D. Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. N Engl J Med. 1979, 301:68-73. 10.1056\/NEJM197907123010202","journal-title":"N Engl J Med"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1979.tb01011.x","article-title":"The pressor actions of noradrenaline, angiotensin II and saralasin in chronic autonomic failure treated with fludrocortisone","volume":"8","author":"Davies B","year":"1979","unstructured":"Davies B, Bannester R, Sever P, Wilcox C. The pressor actions of noradrenaline, angiotensin II and saralasin in chronic autonomic failure treated with fludrocortisone. Br J Clin Pharmacol. 1979, 8:253-60. 10.1111\/j.1365-2125.1979.tb01011.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1042\/CS20130222","article-title":"A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neuropathic compared with hyperadrenergic postural tachycardia syndrome","volume":"126","author":"Ross AJ","year":"2014","unstructured":"Ross AJ, Ocon AJ, Medow MS, Stewart JM. A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neuropathic compared with hyperadrenergic postural tachycardia syndrome. Clin Sci (Lond). 2014, 126:289-96. 10.1042\/CS20130222","journal-title":"Clin Sci (Lond)"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-10-0514","article-title":"Midodrine hydrochloride is effective in the treatment of children with postural orthostatic tachycardia syndrome","volume":"75","author":"Chen L","year":"2011","unstructured":"Chen L, Wang L, Sun J, Qin J, Tang C, Jin H, Du J. Midodrine hydrochloride is effective in the treatment of children with postural orthostatic tachycardia syndrome. Circ J. 2011, 75:927-31. 10.1253\/circj.cj-10-0514","journal-title":"Circ J"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.497594","article-title":"Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome","volume":"111","author":"Raj SR","year":"2005","unstructured":"Raj SR, Black BK, Biaggioni I, Harris PA, Robertson D. Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome. Circulation. 2005, 111:2734-40. 10.1161\/CIRCULATIONAHA.104.497594","journal-title":"Circulation"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000468","article-title":"Droxidopa in the treatment of postural orthostatic tachycardia syndrome","volume":"24","author":"Ruzieh M","year":"2017","unstructured":"Ruzieh M, Dasa O, Pacenta A, Karabin B, Grubb B. Droxidopa in the treatment of postural orthostatic tachycardia syndrome. Am J Ther. 2017, 24:e157-61. 10.1097\/MJT.0000000000000468","journal-title":"Am J Ther"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0b013e3181dd21d2","article-title":"Use of methylphenidate in the treatment of patients suffering from refractory postural tachycardia syndrome","volume":"19","author":"Kanjwal K","year":"2012","unstructured":"Kanjwal K, Saeed B, Karabin B, Kanjwal Y, Grubb BP. Use of methylphenidate in the treatment of patients suffering from refractory postural tachycardia syndrome. Am J Ther. 2012, 19:2-6. 10.1097\/MJT.0b013e3181dd21d2","journal-title":"Am J Ther"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000130847.18666.39","article-title":"Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profiles","volume":"109","author":"Vincent S","year":"2004","unstructured":"Vincent S, Bieck PR, Garland EM, et al.. Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profiles. Circulation. 2004, 109:3202-7. 10.1161\/01.CIR.0000130847.18666.39","journal-title":"Circulation"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1161\/hc0302.102597","article-title":"Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance","volume":"105","author":"Schroeder C","year":"2002","unstructured":"Schroeder C, Tank J, Boschmann M, et al.. Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance. Circulation. 2002, 105:347-53. 10.1161\/hc0302.102597","journal-title":"Circulation"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2018.03.001","article-title":"Vagal nerve stimulation is beneficial in postural orthostatic tachycardia syndrome and epilepsy","volume":"57","author":"Petelin Gadze Z","year":"2018","unstructured":"Petelin Gadze Z, Bujan Kovac A, Adamec I, Milekic N, Sulentic V. Vagal nerve stimulation is beneficial in postural orthostatic tachycardia syndrome and epilepsy. Seizure. 2018, 57:11-3. 10.1016\/j.seizure.2018.03.001","journal-title":"Seizure"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-013-0217-7","article-title":"Endovascular procedures for the treatment of autonomic dysfunction","volume":"24","author":"Gibbons C","year":"2014","unstructured":"Gibbons C, Cheshire W, Barboi A, et al.. Endovascular procedures for the treatment of autonomic dysfunction. Clin Auton Res. 2014, 24:1-2. 10.1007\/s10286-013-0217-7","journal-title":"Clin Auton Res"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2009.02430.x","article-title":"Outcomes of pregnancy in patients with preexisting postural tachycardia syndrome","volume":"32","author":"Kanjwal K","year":"2009","unstructured":"Kanjwal K, Karabin B, Kanjwal Y, Grubb BP. Outcomes of pregnancy in patients with preexisting postural tachycardia syndrome. Pacing Clin Electrophysiol. 2009, 32:1000-3. 10.1111\/j.1540-8159.2009.02430.x","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2018.04.003","article-title":"Surgical and dental considerations in patients with postural tachycardia syndrome","volume":"215","author":"Ruzieh M","year":"2018","unstructured":"Ruzieh M, Dziuba M, Hofmann JP, Grubb BP. Surgical and dental considerations in patients with postural tachycardia syndrome. Auton Neurosci. 2018, 215:119-20. 10.1016\/j.autneu.2018.04.003","journal-title":"Auton Neurosci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/142335-covid-19-induced-postural-orthostatic-tachycardia-syndrome-pots-a-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:23Z","timestamp":1707508523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/142335-covid-19-induced-postural-orthostatic-tachycardia-syndrome-pots-a-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":95,"URL":"https:\/\/doi.org\/10.7759\/cureus.36955","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,31]]}}}